The cationic peptide magainin II is antimicrobial for Burkholderia cepacia-complex strains.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Medical Microbiology

• Publication date

  2009-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1099/jmm.0.008128-0PMID 19502364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure, membrane orientation, mechanism, and function of pexiganan--a highly potent antimicrobial peptide designed from magainin.

  2009influential reference
• Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex.

  2008cited by this paper
• Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology

  2008cited by this paper
• Antimicrobial activity of an abiotic host defense peptide mimic.

  2006cited by this paper
• Proteolytic Degradation of Human Antimicrobial Peptide LL-37 by Bacillus anthracis May Contribute to Virulence

  2006cited by this paper
• Distribution of Burkholderia cepacia Complex Species among Isolates Recovered from Persons with or without Cystic Fibrosis

  2005cited by this paper
• Conserved Structure and Function in the Granulysin and NK-Lysin Peptide Family

  2005cited by this paper
• In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection.

  2005influential reference
• Reconstitution of O-Specific Lipopolysaccharide Expression in Burkholderia cenocepacia Strain J2315, Which Is Associated with Transmissible Infections in Patients with Cystic Fibrosis

  2005cited by this paper
• In Vitro Activity of the Histatin Derivative P-113 against Multidrug-Resistant Pathogens Responsible for Pneumonia in Immunocompromised Patients

  2005influential reference
• Immunomodulatory Activities of Small Host Defense Peptides

  2005cited by this paper
• Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus-Derived Proteinases

  2004influential reference
• Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.

  2004cited by this paper
• The Role of Antimicrobial Peptides in Innate Immunity1

  2003cited by this paper
• Logistic issues and potential prescribing costs associated with use of neuraminidase inhibitors for the treatment of influenza in primary care.

  2003cited by this paper
• MUC7 20-Mer: Investigation of Antimicrobial Activity, Secondary Structure, and Possible Mechanism of Antifungal Action

  2003cited by this paper
• Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

  2003cited by this paper
• Cellular impermeability and uptake of biocides and antibiotics in gram-negative bacteria.

  2002influential reference
• Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37

  2002influential reference
• Antimicrobial peptides of multicellular organisms

  2002influential reference
• A cathelicidin family of human antibacterial peptide LL‐37 induces mast cell chemotaxis

  2002influential reference
• Calcitermin, a novel antimicrobial peptide isolated from human airway secretions

  2001cited by this paper
• Taxonomy and Identification of the Burkholderia cepacia Complex

  2001cited by this paper
• Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence

  2001influential reference
• Fatal Attraction Evaded

  2001cited by this paper
• The outstanding biological stability of beta- and gamma-peptides toward proteolytic enzymes: an in vitro investigation with fifteen peptidases.

  2001cited by this paper
• The Outstanding Biological Stability of β‐ and γ‐Peptides toward Proteolytic Enzymes: An In Vitro Investigation with Fifteen Peptidases

  2001cited by this paper
• A PhoP-Regulated Outer Membrane Protease of Salmonella enterica Serovar Typhimurium Promotes Resistance to Alpha-Helical Antimicrobial Peptides

  2000cited by this paper
• Diagnostically and Experimentally Useful Panel of Strains from the Burkholderia cepacia Complex

  2000cited by this paper
• The role of antimicrobial peptides in animal defenses.

  2000cited by this paper
• In Vitro Activities of Membrane-Active Peptides Alone and in Combination with Clinically Used Antimicrobial Agents against Stenotrophomonas maltophilia

  2000cited by this paper
• Mechanisms for induction of acquired host immunity by neutrophil peptide defensins.

  1999cited by this paper
• Comparative In Vitro Activities of Meropenem, Imipenem, Temocillin, Piperacillin, and Ceftazidime in Combination with Tobramycin, Rifampin, or Ciprofloxacin against Burkholderia cepacia Isolates from Patients with Cystic Fibrosis

  1999cited by this paper
• Biological properties of structurally related alpha-helical cationic antimicrobial peptides.

  1999cited by this paper
• In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa.

  1999cited by this paper
• Biological Properties of Structurally Related α-Helical Cationic Antimicrobial Peptides

  1999influential reference
• In Vitro Antimicrobial Activity of MSI-78, a Magainin Analog

  1998cited by this paper
• Cationic peptides: a new source of antibiotics.

  1998cited by this paper
• Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds.

  1997cited by this paper
• Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity

  1997cited by this paper
• Isolation of an ovine pulmonary surfactant-associated anionic peptide bactericidal for Pasteurella haemolytica.

  1996cited by this paper
• Genomic complexity and plasticity of Burkholderia cepacia.

  1996cited by this paper
• FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.

  1995influential reference
• Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2.

  1995cited by this paper
• The magainins: antimicrobial peptides with potential for topical application.

  1993cited by this paper
• Antitumor activity of magainin analogues against human lung cancer cell lines.

  1992cited by this paper
• All‐D‐magainin: chirality, antimicrobial activity and proteolytic resistance

  1990cited by this paper
• Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.

  1988cited by this paper
• The solution conformation of the antibacterial peptide cecropin A: a nuclear magnetic resonance and dynamical simulated annealing study.

  1988cited by this paper
• Biosynthesis and degradation of peptides derived from Xenopus laevis prohormones.

  1987cited by this paper
• Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

  1984cited by this paper

• Design, synthesis, and anti-tumor activities of novel Brevinin-1BYa peptidomimetics.

  2021cites this paper
• Antimicrobial Peptides: An Approach to Combat Resilient Infections.

  2020cites this paper
• A DedA Family Membrane Protein Is Required for Burkholderia thailandensis Colistin Resistance

  2019cites this paper
• Frog Skin Innate Immune Defences: Sensing and Surviving Pathogens

  2019cites this paper
• An investigation of the effects of an antimicrobial peptide on the survival of Acanthamoeba and intracellular bacteria associated with cystic fibrosis

  2016cites this paper
• Identification of synergists that potentiate the action of polymyxin B against Burkholderia cenocepacia.

  2015cites this paper
• Clinical and in vitro evidence for the antimicrobial therapy in Burkholderia cepacia complex infections

  2015cites this paper
• , Alicia Lipopolysaccharides aeruginosa and Their Interactions with Active against Resistant Pseudomonas New Amphiphilic Neamine Derivatives

  2014cites this paper
• New Amphiphilic Neamine Derivatives Active against Resistant Pseudomonas aeruginosa and Their Interactions with Lipopolysaccharides

  2014cites this paper
• Natural Remedies for the Treatment of Wounds and Wound Infection

  2014cites this paper
• Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia

  2012cites this paper
• Design and characterization of novel hybrid antimicrobial peptides based on cecropin A, LL-37 and magainin II.

  2012cites this paper
• Extreme Antimicrobial Peptide and Polymyxin B Resistance in the Genus Burkholderia

  2011cites this paper
• Extreme Antimicrobial Peptide and Polymyxin B Resistance in the Genus Burkholderia

  2011cites this paper